Antigen-specific humoral and cellular immune response

We are applying a novel vaccine technology to develop vaccines for Animal Health and Veterinary use. Our vaccines are based on the unique S-TIR™ technology platform, which enables the patient’s immune system to generate a powerful and strong immune response after only one or two injections by breaking tolerance to the specific antigens in a reversible way.

The concept of this Next Generation Vaccine Technology has been proven in non-human primates with different B-cell epitopes, T-cell epitopes and recombinant antigen, respectively.